Redwoods Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RWOD and buy or sell other stocks, ETFs, and their options commission-free!About RWOD
Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy.
CEOJoseph Sinkule, PharmD
CEOJoseph Sinkule, PharmD
Employees3
Employees3
HeadquartersOmaha, Nebraska
HeadquartersOmaha, Nebraska
Founded
Founded
Employees3
Employees3
RWOD Key Statistics
Market cap51.06M
Market cap51.06M
Price-Earnings ratio-1.23
Price-Earnings ratio-1.23
Dividend yield—
Dividend yield—
Average volume760.56K
Average volume760.56K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.91
52 Week high$3.91
52 Week low$0.1135
52 Week low$0.1135
Stock Snapshot
The current Redwoods Acquisition(RWOD) stock price is $0.73, with a market capitalization of 51.06M. The stock trades at a price-to-earnings (P/E) ratio of -1.23.
During the trading day, Redwoods Acquisition(RWOD) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Redwoods Acquisition(RWOD) stock has reached 0, versus its average volume of 760.56K.
Over the past 52 weeks, Redwoods Acquisition(RWOD) stock has traded between a high of $3.91 and a low of $0.11.
Over the past 52 weeks, Redwoods Acquisition(RWOD) stock has traded between a high of $3.91 and a low of $0.11.
People also own
Based on the portfolios of people who own RWOD. This list is generated using Robinhood data, and it’s not a recommendation.